RDNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RadNet Inc (RDNT) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst ratings, hedge fund interest, and growth potential in the outpatient diagnostic imaging sector outweigh the current technical weakness and pre-market price dip.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 30.266, and moving averages are converging, showing no clear trend. The stock is trading near its key support level of 64.844, which could act as a floor for the price.
Analysts have initiated coverage with an Overweight rating and a $92 price target, citing strong growth drivers like the hospital-to-outpatient shift and AI benefits.
Hedge funds have significantly increased their buying activity by 139.49% over the last quarter.
The company has shown strong YoY growth in revenue (+13.39%), net income (+68.81%), and EPS (+75%).
Gross margin has dropped significantly (-43.90% YoY), which could indicate cost pressures.
No recent news or major event-driven catalysts to drive immediate price action.
Pre-market price is down by -0.95%, and technical indicators suggest short-term bearish momentum.
In Q3 2025, RadNet's revenue increased by 13.39% YoY to $522.87M. Net income rose by 68.81% YoY to $5.42M, and EPS grew by 75% YoY to $0.07. However, gross margin dropped significantly to 6.25%, down -43.90% YoY.
KeyBanc initiated coverage with an Overweight rating and a $92 price target, citing reasonable growth targets and strong sectoral drivers. Raymond James maintains a Strong Buy rating despite a short report, dismissing its claims as overblown.
